>

Emily Waltenbaugh

  • Vanderbilt University

    Phibbs and VUMC’s Parkinson’s Disease Quality Improvement Committee receive national certification for patient care

    Vanderbilt University Medical Center recently became the nation’s second health care organization to receive The Joint Commission’s (TJC) Gold Seal of Approval for Parkinson’s Disease Certification. A nonprofit organization better known for accrediting hospitals and other health care organizations, TJC, based in Oakbrook Terrace, Illinois, also offers more than 100… Read More

    Dec. 6, 2022

  • Vanderbilt University

    Starnes investigates Duchenne muscular dystrophy patients and likelihood for early age mortality

    by Kelsey Pinckard Duchenne muscular dystrophy (DMD) is a genetic disorder affecting boys and characterized by progressive muscle loss and weakness.   This muscle deterioration eventually involves the heart, culminating in cardiac-related death. While some DMD patients survive into their 40s, others have accelerated… Read More

    Nov. 30, 2022

  • Vanderbilt University

    Honors and Awards – November 2022

    Congratulations to the G3 class who recently celebrated their Halftime Party!   Monika Grabowska (G2) received her first funding support from MPRINT for her pilot study, titled “Developing and Mapping Pediatric Phecodes” AND she received her F30!   Victor Borza (G2) received… Read More

    Nov. 30, 2022

  • Vanderbilt University

    MSTPublications: November 2022

    T cells specific for α-myosin drive immunotherapy-related myocarditis. Axelrod ML, Meijers WC, Screever EM, Qin J, Carroll MG, Sun X, Tannous E, Zhang Y, Sugiura A, Taylor BC, Hanna A, Zhang S, Amancherla K, Tai W, Wright JJ, Wei SC,… Read More

    Nov. 30, 2022

  • Vanderbilt University

    Southeastern Medical Scientist Symposium (SEMSS) Conference

    by Kevin Zhang (M2) and Kaitlin McKernan (G1) The Southeastern Medical Scientist Symposium (SEMSS) annual conference was hosted by The University of Alabama at Birmingham (UAB) MSTP on November 19th-20th. SEMSS is an American Physician Scientists Association (APSA) regional meeting that aims to bring together… Read More

    Nov. 30, 2022

  • Vanderbilt University

    Physician Scientist Speaker Series with Dr. Matthew Schrag

    by Megan Tigue (G2) On the evening of Monday, November 7th, Vanderbilt’s chapter of the American Physician Scientists Association (APSA) held its fall Physician Scientist Speaker Series. This year APSA hosted a cocktail hour and dinner followed by a wonderful talk from Vanderbilt neurologist Matthew Schrag,… Read More

    Nov. 30, 2022

  • Vanderbilt University

    Meet Dr. John Stafford, MSTP Associate Director for Clinical Education

    by Jeewooo Kim (G1) Dr. John M. Stafford is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism and Molecular Physiology and Biophysics. He is also the Associate Director for Clinical Education for the Vanderbilt MSTP. His lab focuses on obesity and… Read More

    Nov. 30, 2022

  • Vanderbilt University

    Reid investigates high risk breast cancer genes and needs for surgical treatment

    Women with inherited mutations in breast cancer genes have lifetime varying breast cancer risks, ranging from high (e.g., 40% or more for BRCA1, BRCA2, PALB2) to moderate (e.g., 20% or higher for ATM, CHEK2) risk genes.  Per national practice guidelines, risk-reducing bilateral mastectomy is a consideration for patients with inherited… Read More

    Nov. 25, 2022

  • Vanderbilt University

    Tsosie to be ASU’s first Indigenous human geneticist

    Krystal Tsosie, MPH (Diné/Navajo Nation) is an advocate for Indigenous genomic and data sovereignty. She is a co-founder of the first U.S. Indigenous-led biobank, a 501(c)3 nonprofit research institution called the Native BioData Consortium. Her current research at Arizona State University centers on ethical engagement with Indigenous communities to ensure Indigenous… Read More

    Nov. 17, 2022

  • Vanderbilt University

    Moderna’s COVID-19 vaccine proves save for young children from 6 months to 5 years, says Creech

    Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found. Results of the two-part KidCOVE study of nearly 13,000 children conducted last year at 87 sites in… Read More

    Nov. 15, 2022